Avantor Stock Today

AVTR Stock  USD 21.06  0.02  0.1%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 5

 
High
 
Low
Very Low
Avantor is selling at 21.06 as of the 30th of November 2024; that is 0.1 percent increase since the beginning of the trading day. The stock's lowest day price was 20.89. Avantor has under 5 % chance of experiencing financial distress over the next 2 years, but has generated negative returns over the last 90 days. Note, on October 8, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of Avantor's common stock.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
17th of May 2019
Category
Healthcare
Classification
Health Care
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania. The company has 680.61 M outstanding shares of which 31.9 M shares are presently shorted by private and institutional investors with about 4.86 trading days to cover. More on Avantor

Moving together with Avantor Stock

  0.68A Agilent Technologies Sell-off TrendPairCorr
  0.92ME 23Andme Holding Upward RallyPairCorr
  0.77VALN Valneva SE ADRPairCorr

Moving against Avantor Stock

  0.79DRUG Bright Minds Biosciences TrendingPairCorr
  0.73VCYT VeracytePairCorr
  0.67VERA Vera TherapeuticsPairCorr
  0.64VCEL Vericel Corp OrdPairCorr
  0.6VANI Vivani MedicalPairCorr
  0.31DMAC DiaMedica Therapeutics TrendingPairCorr

Avantor Stock Highlights

ESG Sustainability
Environmental
Governance
Social
CEOMichael Stubblefield
Business ConcentrationLife Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, SP Midcap 400, Health Care, Life Sciences Tools & Services, Specialty Chemicals, Basic Materials (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.420.5371
Significantly Down
Pretty Stable
Gross Profit Margin0.410.3393
Fairly Up
Slightly volatile
Net Debt4.7 B5.3 B
Fairly Down
Slightly volatile
Total Current Liabilities1.3 B1.5 B
Fairly Down
Slightly volatile
Non Current Liabilities Total6.6 B6.2 B
Notably Up
Slightly volatile
Total Assets11.2 B13 B
Fairly Down
Slightly volatile
Total Current Assets2.2 B2.4 B
Significantly Down
Slightly volatile
Debt Levels
Avantor can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Avantor's financial leverage. It provides some insight into what part of Avantor's total assets is financed by creditors.
Liquidity
Avantor currently holds 5.54 B in liabilities with Debt to Equity (D/E) ratio of 1.46, which is about average as compared to similar companies. Avantor has a current ratio of 1.61, which is within standard range for the sector. Note, when we think about Avantor's use of debt, we should always consider it together with its cash and equity.

Begin Period Cash Flow

217.41 Million
Avantor (AVTR) is traded on New York Stock Exchange in USA. It is located in Radnor Corporate Center, Radnor, PA, United States, 19087 and employs 14,500 people. Avantor is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 14.33 B. Avantor conducts business under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 680.61 M outstanding shares of which 31.9 M shares are presently shorted by private and institutional investors with about 4.86 trading days to cover. Avantor currently holds about 242.6 M in cash with 870 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36.
Check Avantor Probability Of Bankruptcy
Ownership Allocation
The majority of Avantor outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Avantor to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Avantor. Please pay attention to any change in the institutional holdings of Avantor as this could imply that something significant has changed or is about to change at the company. On October 8, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of Avantor's common stock.
Check Avantor Ownership Details

Avantor Stock Institutional Holders

InstituionRecorded OnShares
Amvescap Plc.2024-06-30
9.9 M
1832 Asset Management L.p2024-09-30
9.1 M
Norges Bank2024-06-30
8.1 M
Ubs Asset Mgmt Americas Inc2024-09-30
8.1 M
Durable Capital Partners Lp2024-09-30
M
Bessemer Group Inc2024-06-30
7.5 M
Bank Of America Corp2024-06-30
6.9 M
Morgan Stanley - Brokerage Accounts2024-06-30
6.8 M
Sam Sustainable Asset Management Ltd2024-09-30
6.8 M
Dodge & Cox2024-09-30
68.4 M
T. Rowe Price Investment Management,inc.2024-09-30
67.1 M
View Avantor Diagnostics

Avantor Historical Income Statement

At this time, Avantor's Income Before Tax is relatively stable compared to the past year. As of 11/30/2024, Net Income Applicable To Common Shares is likely to grow to about 799.7 M, while Selling General Administrative is likely to drop slightly above 1.2 B. View More Fundamentals

Avantor Stock Against Markets

Avantor Corporate Management

Joseph MassaroIndependent DirectorProfile
Christophe MBAExecutive AMEAProfile
Lan KangIndependent DirectorProfile
Tanya FoxeExecutive Vice President - Global Operations and Supply ChainProfile

Already Invested in Avantor?

The danger of trading Avantor is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Avantor is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Avantor. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Avantor is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.

Additional Tools for Avantor Stock Analysis

When running Avantor's price analysis, check to measure Avantor's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avantor is operating at the current time. Most of Avantor's value examination focuses on studying past and present price action to predict the probability of Avantor's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avantor's price. Additionally, you may evaluate how the addition of Avantor to your portfolios can decrease your overall portfolio volatility.